Mybucod 10 mg/200 mg/350 mg FC tablets
PDF Leaflet Revision Date: 24 October 2025
Clinical Summary
Quick overview from the medicine insert
Indication
Relief of mild to moderate pain or fever of inflammatory origin.
Dosage (summary)
Adults: 1-2 tablets every 4 hours, max 6 tablets/24 hours. Not for children under 12.
Onset of Action / Duration
Onset: 30 mins, Duration: 6-8 hours
Special Populations
- Elderly
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Not recommended during pregnancy or breastfeeding; risks of fetal harm and neonatal respiratory depression.
Key Drug Interactions
- MAOIs
- Anticoagulants
- Alcohol
- CYP2D6 inhibitors
Contraindications
- Hypersensitivity to components
- Acute respiratory depression
- Heart failure
- Active peptic ulcer disease
- Breastfeeding
- Third trimester pregnancy
Common side effects
- Gastrointestinal upset
- Drowsiness
- Dizziness
- Constipation
- Nausea
Counselling Points
- Do not exceed recommended dose
- Avoid alcohol
- Consult if pain persists beyond 5 days
- Monitor for signs of respiratory depression
Serious warnings
- Risk of dependency and addiction
- Severe cutaneous adverse reactions
- Gastrointestinal bleeding
- Liver damage in overdose
Important Disclaimer
The Mybucod 10 mg/200 mg/350 mg FC tablets professional information leaflet below is the property of Pharmacare and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
